Renal Denervation Technologies Market is Anticipated to Increase at a Prolific CAGR of 40% by 2026

The global renal denervation technologies market is anticipated to surge ahead at a stellar CAGR of 40% from 2022 to 2026.

The increasing prevalence of lifestyle disorders such as hypertension due to a rise in sedentary and stressful lifestyles, alcoholic and tobacco use, poor eating habits, and escalating senior population are driving market expansion. The benefits of renal denervation technologies such as speedy recovery, security, convenience, and cost-effectiveness are acting as significant growth-inducing factors.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7587?PS

Catheter-based procedures to remove renal nerves have demonstrated significant outcomes. Additionally, catheter-based techniques seem to be less risky for patients and make the denervation of particular nerves easier. Factors projected to propel demand growth for renal denervation technologies are increased prevalence of hypertension with ineffective anti-hypertensive medications, long-lasting effect of renal denervation, and constant advancements in renal denervation devices.

Due to benefits such as improved safety, shorter treatment times, permanent effects, and an increase in uncontrolled and treatment-resistant hypertension in the urban population as a result of changing lifestyle habits, the market for renal denervation technologies and related processes is set to surge at a rapid pace over the coming years.

𝐖𝐡𝐚𝐭'𝐬 𝐒𝐡𝐚𝐩𝐢𝐧𝐠 𝐑𝐞𝐧𝐚𝐥 𝐃𝐞𝐧𝐞𝐫𝐯𝐚𝐭𝐢𝐨𝐧 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡?

"Increase in Funding for R&D Initiatives for Treatment of Renal Disorders"

Demand for renal denervation procedures is anticipated to be aided by various authorities and government organizations increasing funding for R&D initiatives for renovascular hypertension treatment. Additionally, advancements in renal denervation devices could propel the industry.

One of the key factors increasing the adoption of the renal denervation method is the number of new skills it introduces. The drawbacks of high frequency-based renal denervation systems can be overcome by an ultrasonic RDN device. Without making direct touch with the tissue, high-frequency sound waves and ultrasonic energy assist in the removal of nerves.

This lessens the risk of renal artery injury. This quality makes this method preferred by a sizable number of patients worldwide. The effectiveness of these strategies will also be greatly enhanced by incorporating technology into these kinds of health practices and paving the opportunities in the renal denervation industry.

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐑𝐞𝐧𝐚𝐥 𝐃𝐞𝐧𝐞𝐫𝐯𝐚𝐭𝐢𝐨𝐧 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐒𝐮𝐫𝐯𝐞𝐲

By Product:

Symplicity
Vessix
EnligHTN
Paradise
Iberis
Others

By Technology:

Radiofrequency-based
Ultrasound-based
Micro-infusion-based

By End User:

Hospitals
Specialty Clinics
Research & Academic Institutes
Ambulatory Care Centers

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Winning Strategy

Renal denervation device manufacturing companies are taking steps to increase their presence in the global market, such as innovative product releases and collaborations. Leading businesses are making significant investments to differentiate themselves from one another and flourish in the current market environment. Market players are also encouraged to use creative marketing techniques to promote the use of renal denervation devices.

For instance,

In 2021, The Paradise Ultrasound Renal Denervation System was introduced by ReCor Medical. The special product is anticipated to simplify patient diagnosis of uncontrolled hypertension throughout Germany.

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐑𝐞𝐧𝐚𝐥 𝐃𝐞𝐧𝐞𝐫𝐯𝐚𝐭𝐢𝐨𝐧 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7587?PS

𝐊𝐞𝐲 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐑𝐞𝐧𝐚𝐥 𝐃𝐞𝐧𝐞𝐫𝐯𝐚𝐭𝐢𝐨𝐧 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

Medtronic
Boston Scientific Corp.
Symple Surgical, Inc.
Terumo Corporation
Ablative Solutions, Inc.
Abbott Laboratories
Renal Dynamics Limited
Mercator MedSystems, Inc.
ReCor Medical, Inc.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐑𝐞𝐧𝐚𝐥 𝐃𝐞𝐧𝐞𝐫𝐯𝐚𝐭𝐢𝐨𝐧 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

• Global renal denervation technologies market to reach valuation of US$ 720 million by 2026.
• Market in Germany set to expand at CAGR of 33% over forecast period.
• Demand for ultrasound-based technologies projected to rise at 37% CAGR through 2026.
• Market in Canada expected to rise at CAGR of 36% from 2022 to 2026.

Contact:

Us Sales Office :
11140 Rockville Pike
Suite 400
Rockville, Md 20852
United States
Tel: +1 (628) 251-1583

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.